The problem the researchers set out to solve is one of complementary blind spots. Nano-sized zinc oxide is an excellent ultraviolet shield: it absorbs and scatters UV photons before they can trigger the free-radical chain reactions that photo-oxidize bitumen, with earlier studies suggesting best protection at dosages of roughly three to five percent. Yet zinc oxide does almost nothing to slow thermo-oxidative aging, the process by which oxygen attacks bitumen molecules at elevated temperatures while light hydrocarbon fractions evaporate. Layered silicates such as expanded vermiculite behave in the opposite way. When their sheets exfoliate and disperse through the binder, they form tortuous physical barriers that block the diffusion of oxygen and heat into the bitumen interior, but they offer limited protection against ultraviolet light. Other popular nanoparticles, including titanium dioxide and silica, suffer from similar one-sided protection or compromise low-temperature performance.

Earlier attempts to pair these materials relied on simple physical blending, in which zinc oxide powder and organically modified vermiculite are stirred together into hot bitumen. That approach is easy to execute but produces uneven dispersion and weak interfacial bonding, so the two components never fully deliver their combined potential. The Chinese team instead used homogeneous precipitation chemistry to grow zinc oxide directly on the surface of expanded vermiculite layers. Zinc acetate dihydrate and urea are dissolved in water with the vermiculite; as the mixture is heated, urea slowly hydrolyzes to release hydroxide ions, which react with zinc ions to precipitate zinc oxide precursors uniformly across the mineral surfaces. A final calcination step converts those precursors into crystalline zinc oxide nanoparticles, and treatment with the surfactant cetyltrimethylammonium bromide improves compatibility with the bitumen matrix.

Crucially, the properties of the resulting composite depend sensitively on how it is made. Zinc source concentration controls how much zinc oxide is loaded onto the carrier; reaction temperature governs the hydrolysis rate and particle size; stirring rate influences how well particles anchor to the vermiculite; and calcination temperature determines crystallinity and ultraviolet absorption. To find the best recipe without running every possible combination, the team employed an L9 orthogonal design, testing four factors at three levels in just nine experiments. They then evaluated each composite by blending it into a 70# paving-grade bitumen at a fixed five percent dosage and measuring how well the modified binder resisted short-term oven aging and long-term ultraviolet exposure, tracking changes in softening point and viscosity.

The range analysis of those experiments revealed a clear hierarchy of influence: zinc source concentration mattered most, followed by stirring rate, then reaction temperature, with calcination temperature the least influential. Two factors behaved in opposite directions depending on the aging regime. Higher zinc concentration improved resistance to both heat and UV aging, but elevated reaction temperature, while boosting UV protection by raising the zinc oxide fraction, slightly weakened protection against thermo-oxidative aging because it left relatively less of the barrier-forming vermiculite. Stirring rate and calcination temperature both showed non-monotonic behavior, with performance peaking at 250 revolutions per minute and 450 degrees Celsius; beyond those points, excessive agitation disrupted particle anchoring and overheating caused zinc oxide particles to over-crystallize and agglomerate, shrinking their active surface area.

Balancing these trade-offs, the optimal synthesis conditions emerged as a zinc source concentration of 1.5 moles per liter, a reaction temperature of 90 degrees Celsius, a stirring rate of 250 revolutions per minute, and calcination at 450 degrees Celsius. Because that combination was not among the nine original runs, the researchers prepared a confirmation batch under the predicted optimum. The verification was emphatic: bitumen modified with the optimally synthesized composite showed a softening point increment difference of 2.1 degrees Celsius and a viscosity aging index difference of 32.8 percentage points after short-term aging, and corresponding differences of 2.0 degrees Celsius and 47.2 percentage points after ultraviolet aging, confirming the reliability of the statistical optimization.

With the best recipe in hand, the team turned to the question of dosage, testing loadings of one, three, five, and seven percent by weight across three aging protocols: the thin-film oven test simulating short-term aging, the pressure aging vessel reproducing five to seven years of field service in twenty hours, and twelve days of ultraviolet irradiation at sixty degrees Celsius. Rheological measurements with a dynamic shear rheometer showed that the composite stiffens the binder in a dosage-dependent way, with the five percent blend achieving the highest complex shear modulus at sixty degrees Celsius, roughly 17.3 percent above the unmodified base bitumen, while simultaneously lowering the phase angle, meaning the binder became more elastic and better able to recover from deformation.

The five percent dosage proved to be a genuine sweet spot across nearly every metric. It produced the lowest creep stiffness and highest creep-rate value in bending beam tests at low temperatures, expanding the safety margin against thermal cracking even though the discrete low-temperature performance grade remained unchanged. Its fatigue factor was 12.0 percent below that of the base bitumen, indicating superior resistance to fatigue damage. Multiple stress creep recovery tests revealed an interesting competition between mechanisms: at low dosages the composite’s anti-aging effect dominates, keeping the aged binder softer and more deformable, while at seven percent the dense platelet network begins to physically stiffen the matrix, overriding the protective softening. Chemical analysis by infrared spectroscopy showed the same pattern at the molecular level, with the five percent blend suppressing the growth of carbonyl and sulfoxide aging indices by 28.7 and 65.0 percent respectively after pressure vessel aging.

The physical aging data told perhaps the most striking story. After long-term thermo-oxidative aging, the five percent modified bitumen reduced the softening point increment and viscosity aging index by 2.0 degrees Celsius and 179.4 percentage points relative to the base binder, and after ultraviolet aging the corresponding reductions were 1.5 degrees Celsius and 43.8 percentage points. Rutting factor aging indices fell by as much as 92.6 percent after short-term aging and 385.4 percentage points after long-term pressure aging at the optimal dosage. The authors attribute this dual protection to a clean division of labor: exfoliated vermiculite lamellae form a barrier network that impedes oxygen and heat diffusion, while zinc oxide nanoparticles anchored on those lamellae absorb and scatter ultraviolet radiation before radical chain reactions can begin. Beyond five percent, additional modifier adds little barrier density while its filler effect begins to offset the anti-aging gains.

The practical implications are considerable. Roads represent one of the largest material flows on the planet, and extending pavement service life even modestly would save enormous quantities of energy, aggregate, and bitumen while reducing maintenance-related disruption. By establishing both a reproducible synthesis procedure and a defensible dosage recommendation, the study provides the synthesis-to-application bridge that earlier work on this composite lacked. The authors caution that scale-up still requires pilot-scale mass and energy balances, evaluation of acid and alkali consumption, calcination energy demands, wastewater management, and life-cycle assessment before widespread deployment. They also recommend supplementing the fatigue screening used here with time-sweep tests and mixture-level fatigue experiments, and extending the tested ranges of zinc concentration and reaction temperature to confirm that the boundary levels chosen remain optimal. For now, though, the message is clear: a humble mineral, vermiculite, dressed with carefully grown zinc oxide nanocrystals, can help the black binder beneath our wheels stay younger for longer.

Subject of Research: ZnO/expanded vermiculite nanocomposite modification of bitumen for anti-aging performance

Article Title: Synthesis parameter optimization and dosage-dependent reinforcing effects of ZnO/EV on rheological and aging behavior of bitumen

Article References: Synthesis parameter optimization and dosage-dependent reinforcing effects of ZnO/EV on rheological and aging behavior of bitumen. (n.d.). https://doi.org/10.1016/j.cscm.2026.e06513

Image Credits: AI Generated

DOI: 10.1016/j.cscm.2026.e06513

Keywords: bitumen, zinc oxide, expanded vermiculite, nanocomposite, anti-aging, rheology, ultraviolet aging, thermo-oxidative aging, asphalt pavement, orthogonal design, dynamic shear rheometer, FTIR

Imagine that you are in your sixties or seventies, and on a brisk walk. Your muscles contract, setting off small waves of calcium and other signaling molecules. In response, your skeletal muscle cells secrete a host of myokines into your bloodstream—molecules such as interleukin-6 (IL-6) and irisin. Meanwhile, your adipose tissue, sensing metabolic demands, releases adipokines that fine-tune insulin sensitivity. Your liver, stirred by changes in blood flow and metabolic substrates, sends out hepatokines such as fibroblast growth factor 21 (FGF21). And your bones, subjected to the forces of gravity and muscle tension, secrete osteocalcin or other osteokines that preserve skeletal integrity. Even your brain—through glial cells or neurons—contributes neurokines that bolster synaptic plasticity. All these exerkines then travel through the bloodstream, coordinating with different organs, collectively pushing back against the harmful effects of age-related stress and inflammation.

It is well known that aging coincides with a series of systemic changes—reduced muscle mass (sarcopenia), diminishing bone density (osteoporosis), elevated inflammation (“inflammaging”), and a decline in mitochondrial quality. The danger is that these changes feed into each other, leading to a spiraling loss of vitality. But the exerkines triggered by regular physical activity can break this vicious cycle. For instance, certain exerkines promote a shift away from chronic inflammation by boosting the production of anti-inflammatory mediators like interleukin-10 (IL-10) and restricting pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α). Others enhance the oxidative capacity of skeletal muscle, reducing the accumulation of reactive oxygen species (ROS) and preventing mitochondrial decay—major contributors to cellular dysfunction in older adults.

Scientists have begun to pinpoint precisely how exerkines exert these protective effects. One factor is the well-known molecule IL-6, which can exhibit pro-inflammatory behavior in certain contexts but acts as an anti-inflammatory signal during and immediately after exercise. Another is irisin, a hormone-like factor that helps convert white adipose tissue into a more metabolically active “beige” fat, raising one’s resting energy expenditure while improving insulin sensitivity and metabolic health. Meanwhile, fibroblast growth factor 21 (FGF21), secreted mainly by the liver, exerts beneficial effects on glucose control and lipid metabolism, thus lowering one’s vulnerability to type 2 diabetes. Myostatin, once considered only a negative regulator of muscle growth, has emerged as a possible modulator of tumor suppression. Apelin, another exerkine, fosters the health of both bone and muscle tissue, helping older bodies withstand the rigors of daily life. And in the brain, molecules like clusterin or glycosylphosphatidylinositol-specific phospholipase D1 (GPLD1) can dampen inflammation and shore up neural plasticity, safeguarding cognition in older adults.

At first, it may sound like an astonishing synergy: how can the same physical movement help the heart, bones, muscles, immune system, and even the brain? But the body’s architecture is deeply interconnected, and exerkines serve as the biochemical messengers that tie all these benefits together. Perhaps the clearest example is skeletal muscle, the largest organ by mass in most people, which rapidly communicates with other tissues during a workout. The molecular signals it emits—the myokines—can travel to the liver to promote better fat oxidation, or to the brain to encourage synaptic plasticity. They may also act on the immune cells, fine-tuning the balance between pro-inflammatory and anti-inflammatory signaling. Likewise, adipose tissue secretes adiponectin, which fosters fatty acid oxidation and reduces insulin resistance in muscle and liver, while also modulating inflammatory processes system-wide. This level of cross-organ “conversation” explains why a simple brisk walk or a few sets of resistance exercises per week can lower the risk of so many age-related conditions—from cardiovascular disease and type 2 diabetes to osteoporosis and some cancers.

Given the multiplicity of exerkines, it should be no surprise that different forms of exercise generate distinct benefits. The recommendation for older adults, proposed by various international guidelines, generally includes a combination of resistance training, aerobic exercise, and balance activities. Resistance or weight training stimulates muscle hypertrophy and strength gains, spurring the release of exerkines that specifically promote muscle repair and anabolism. Aerobic exercises like walking, jogging, or cycling, at intensities around 55–70% of maximum heart rate, are associated with improved cardiovascular function, higher levels of beneficial cytokines such as IL-10, and better glycemic control. Balance and flexibility exercises, such as yoga and tai chi, are no less important; they may not generate as high an acute exerkine surge as intense resistance training or cardio, but they do help preserve neuromuscular coordination and reduce the risk of falls—a critical factor in healthy aging.

One of the cornerstones of exerkine research is the notion that improving mitochondrial function is a central mechanism of “exercise as medicine.” With age, mitochondria in cells become less efficient at producing ATP (adenosine triphosphate), and they accumulate oxidative damage. Exercise can mitigate this by increasing the expression of key enzymes like glutathione peroxidase (GPx), superoxide dismutase (SOD), and heme oxygenase-1 (HO-1), which help neutralize free radicals. ROS no longer run rampant, so the negative feedback loop leading to further mitochondrial damage is dampened. Meanwhile, exerkines promote the production of peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α), a major driver of mitochondrial biogenesis. As a result, older individuals who engage in physical activity can regenerate healthier mitochondria, thus powering their cells more effectively. The payoff is less cellular senescence, improved nutrient sensing, and often a reduction in chronic inflammation.

It is important to note that the synergy between exercise and exerkines extends into domains like cognitive function. Regular training fosters a rise in brain-derived neurotrophic factor (BDNF), a neurotrophin essential for neuronal survival, synaptic plasticity, and hippocampal neurogenesis. This helps guard against the cognitive deficits associated with disorders such as Alzheimer’s disease. Some exerkines, such as glycosylphosphatidylinositol-specific phospholipase D1 (GPLD1) and platelet factor 4 (CXCL4), have also been implicated in hippocampal neurogenesis, encouraging the generation of new neurons and reversing certain aspects of age-related mental decline. These discoveries resonate strongly with observational data showing that physically active older adults frequently show slower cognitive decline and lower incidence of neurodegenerative conditions.

For those concerned about type 2 diabetes, exercise again steps in with an exerkine-mediated strategy. Muscle contraction not only draws glucose into cells via transporters like GLUT4, it also triggers the release of certain hepatokines from the liver and adipokines from fat that normalize blood sugar levels. FGF21, for instance, fosters insulin sensitivity, while HSP72 (heat shock protein 72) can prevent misfolded protein accumulation in pancreatic beta cells. Even short bursts of activity can drive these beneficial changes. Though many older people worry about whether they can safely engage in vigorous workouts, the research points to moderate, consistent habits—like walking daily or lifting light weights multiple times a week—as enough to catalyze these systemic benefits.

Another striking area of discovery is the way exerkines appear to influence bone health. Osteocalcin, produced by bone in response to the mechanical load from weight-bearing exercise, helps maintain bone mineral density and appears to have metabolic functions that extend beyond bone. It may, for example, improve insulin sensitivity. Meanwhile, molecules such as TGF-β1 and apelin, also upregulated by exercise, can help coordinate bone formation and muscle mass. For older adults whose bones grow increasingly fragile, these factors are a ticket to reduced fracture risk and better musculoskeletal resilience. In some scenarios, the synergy between osteokines and myokines can help accelerate bone healing after injury or surgery, a tremendous boon for those in advanced age.

Add to this the remarkable possibility that exerkines carry at least some anti-cancer properties, and exercise’s significance in health management gains still more luster. Myostatin, ironically known for suppressing muscle growth, has recently been linked to anti-tumor functions in certain tissues, possibly by dampening pathways that drive unchecked proliferation. Irisin, once studied for its effect on adipose tissue browning, also shows promise as an anti-tumor agent in preclinical models, often by boosting the immune system’s detection of malignant cells or by altering local inflammatory signals that help tumors thrive. Even though these studies are preliminary, they open an exciting dimension of research: perhaps a consistent exercise routine could lower both the risk of developing cancer and, in some cases, slow progression for those who already have it.

Despite the avalanche of positive evidence, we must tread carefully. Not all forms or intensities of exercise deliver uniform exerkine responses. Overtraining—exercising too vigorously or too frequently—can create oxidative stress or immune suppression, especially in older individuals who may have other comorbidities. The goal, therefore, is moderation and personalization: designing a plan that taps into the beneficial exerkine output without overwhelming the body’s capacity to recover. Many new areas of research revolve around “exercise mimetics,” compounds that mimic the effect of exerkines by targeting the same molecular pathways. For individuals too frail to exercise adequately, such compounds could theoretically provide the health benefits of a workout. But the nuance is that exercise is not merely a pill to be replaced; it sets in motion large-scale mechanical, neural, and metabolic processes that may not be fully replicated by a single compound or cocktail.

What will the future hold for this intriguing domain of exerkines and anti-aging strategies? One possibility is that health practitioners will monitor exerkine levels in the bloodstream to gauge whether an older adult’s exercise regimen is truly effective. Another is that gene- or cell-based therapies could selectively increase expression of beneficial exerkines, or block “rogue” molecules that hamper healthy aging. As more is uncovered about how these molecules act and interact, a new generation of geriatric medicine could arise, leveraging exerkines to combat conditions as diverse as Alzheimer’s, frailty, and diabetes. Pharmacologists already see exerkines as potential “druggable” targets. For instance, if we can harness the browning effect of irisin safely, we might treat obesity without radical changes in diet. If we can modulate clusterin or BDNF effectively, we might slow cognitive decline. Conversely, controlling overactive inflammatory exerkines in certain autoimmune settings might stave off age-associated autoimmune conditions.

Yet, in the midst of all these futuristic innovations, the core message remains clear: regular movement, even in modest doses, is already our best bet for “turning on” these beneficial exerkines. Where certain pharmaceutical avenues may take years to become safe and widely available, everyday exercise is accessible now, with little risk and abundant upside. Medical experts emphasize that older adults should combine strategies: build in some resistance training to preserve muscle mass and bone density, incorporate aerobic exercise to bolster cardiovascular and metabolic function, and do balance activities to reduce fall risk and maintain neural reflexes. These are not complicated tasks, but the molecular payoffs—in the form of exerkine release—can be profound.

Ultimately, the story of exercise-induced exerkines is one of the most compelling examples of how our bodies are designed for movement, and how that movement orchestrates a symphony of positive biological signals. By activating these signals through conscious, consistent activity, we tap into a powerful, evolution-built mechanism that defends us against the degradations of time. Gone are the days when we could think of exercise merely as a means to burn calories. Instead, each session of walking, resistance training, or mindful balance exercises sets off thousands of molecular changes that can be harnessed to keep us healthier for longer. It is a powerful illustration that our biology wants us to move, and in moving, we coax our cells to produce molecules that can keep the ravages of age at bay.

As researchers continue to refine our understanding, we may see more targeted advice on the most effective exercise “doses,” frequencies, and intensities for stimulating beneficial exerkines. We may also see novel interventions that help older adults overcome barriers to physical activity, from wearable technology that tracks functional movement patterns to community programs aimed at delivering personalized exercise regimens. If further breakthroughs arrive with safe and effective exercise mimetics, so much the better. Yet for now, the basic science underscores a unifying conclusion: exercise remains one of our most potent forms of preventive medicine, not just for the muscle and cardiovascular advantages, but for the invisible molecular crosstalk that might very well determine how gracefully and how long we age.

Subject of Research: Exercise and Exerkines in Anti-Aging and Disease Prevention
Article Title : Exercise and Exerkines: Mechanisms and Roles in Anti-Aging and Disease Prevention
News Publication Date : February 2025
Article Doi References : https://doi.org/10.1016/j.exger.2025.112685
Keywords : Exerkines, Anti-aging, Exercise Physiology, Mitochondrial Function, Muscle Mass, Inflammaging, Cognitive Decline, Metabolic Homeostasis, Bone Density